PKHD1 and malignant colon neoplasm: The current study investigated a cohort of 436 colon cancer patients and revealed that individuals with PKHD1 somatic mutations experienced significantly poorer overall survival outcomes compared to those without the mutation (p = 0.0058, Figure 2A).